Wedell-Wedellsborg Johan 4
4 · Y-mAbs Therapeutics, Inc. · Filed Dec 11, 2023
Insider Transaction Report
Form 4
Wedell-Wedellsborg Johan
Director10% Owner
Transactions
- Purchase
Common Stock
2023-12-11$7.01/sh+102,863$720,843→ 4,552,778 total(indirect: By WG Biotech ApS) - Purchase
Common Stock
2023-12-07$6.50/sh+6,183$40,190→ 4,431,412 total(indirect: By WG Biotech ApS) - Purchase
Common Stock
2023-12-08$6.99/sh+18,503$129,379→ 4,449,915 total(indirect: By WG Biotech ApS)
Footnotes (4)
- [F1]This transaction was executed in multiple trades each at price of $6.50. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F2]This transaction was executed in multiple trades at prices ranging from $6.90 to $7.00. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F3]This transaction was executed in multiple trades at prices ranging from $6.86 to $7.15. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F4]Reporting Person is the majority owner of WG Biotech ApS and as such has sole voting and dispositive power with respect to such shares.